Furthermore, the combined use of cetuximab and β-elemene, a bioactive compound isolated from the Chinese herb Curcumae Rhizoma, sensitizes KRAS-mutant CRC cells by inducing ferroptosis, accompanied by ROS accumulation and GSH depletion [41]. This evidence concerns the gene KRAS and colorectal carcinoma.